603669.SS

Lionco Pharmaceutical Group Co.,Ltd. [603669.SS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

603669.SS Stock Summary

Top 10 Correlated ETFs

603669.SS


Top 10 Correlated Stocks

603669.SS


In the News

603669.SS Financial details

Company Rating
Neutral
Market Cap
3.01B
Income
-222.86M
Revenue
188.72M
Book val./share
1.24
Cash/share
1.08
Dividend
-
Dividend %
-
Employees
497
Optionable
No
Shortable
Yes
Earnings
20 Oct 2023
P/E
-20.85
Forward P/E
-
PEG
0.5
P/S
21.18
P/B
4.49
P/C
3.7
P/FCF
-20.36
Quick Ratio
2.99
Current Ratio
3.24
Debt / Equity
0.63
LT Debt / Equity
0.42
-
-
EPS (TTM)
-0.28
EPS next Y
-
EPS next Q
-
EPS this Y
-377.78%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-29.57%
Revenue Q/Q
-4.73%
EPS Q/Q
-47.21%
-
-
-
-
SMA20
-
SMA50
-33.33%
SMA100
-20%
Inst Own
-
Inst Trans
-
ROA
-12%
ROE
-21%
ROC
-0.15%
Gross Margin
40%
Oper. Margin
-114%
Profit Margin
-118%
Payout
-2%
Shs Outstand
717.62M
Shs Float
328.15M
-
-
-
-
Target Price
-
52W Range
2.94-6.07
52W High
-33.33%
52W Low
+100%
RSI
44
Rel Volume
1.04
Avg Volume
7.13M
Volume
7.43M
Perf Week
-7.19%
Perf Month
22.32%
Perf Quarter
-
Perf Half Y
-22.63%
-
-
-
-
Beta
0.248383
-
-
Volatility
0.16%, 0.26%
Prev Close
2.3%
Price
4
Change
-0.25%

603669.SS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
2.352.291.381.030.37
Net income per share
0.260.280.220.09-0.25
Operating cash flow per share
0.260.330.170.18-0.08
Free cash flow per share
0.020.320.090.1-0.14
Cash per share
0.981.212.42.191.23
Book value per share
1.941.842.032.041.45
Tangible book value per share
1.871.771.891.861.3
Share holders equity per share
1.941.842.032.041.45
Interest debt per share
0.560.371.51.350.8
Market cap
3.63B3.74B6.27B7.15B4.49B
Enterprise value
3.32B3.48B5.78B7.11B4.54B
P/E ratio
19.8818.5539.18108.44-22.96
Price to sales ratio
2.182.296.279.6515.54
POCF ratio
19.5415.8849.4655.61-67.73
PFCF ratio
298.2716.6496.6996.99-41.16
P/B Ratio
2.642.854.244.93.96
PTB ratio
2.642.854.244.93.96
EV to sales
1.992.135.789.615.69
Enterprise value over EBITDA
13.7712.7324.3851.82-37.42
EV to operating cash flow
17.8414.7745.655.32-68.4
EV to free cash flow
272.2915.4889.1596.47-41.56
Earnings yield
0.050.050.030.01-0.04
Free cash flow yield
00.060.010.01-0.02
Debt to equity
0.290.190.730.650.55
Debt to assets
0.190.130.40.380.33
Net debt to EBITDA
-1.31-0.95-2.06-0.27-0.36
Current ratio
2.633.062.792.763.74
Interest coverage
94.2216.3816.064.59-28.14
Income quality
1.021.170.791.950.34
Dividend Yield
0.030.070.020.020.02
Payout ratio
0.581.390.712.42-0.41
Sales general and administrative to revenue
0.010.010.020.020.05
Research and developement to revenue
0.010.020.020.030.11
Intangibles to total assets
0.020.030.040.050.06
Capex to operating cash flow
-0.93-0.05-0.49-0.430.65
Capex to revenue
-0.1-0.01-0.06-0.07-0.15
Capex to depreciation
-5.85-0.31-1.65-1.27-0.95
Stock based compensation to revenue
0000-0.02
Graham number
3.353.423.172.062.86
ROIC
0.110.130.060.03-0.1
Return on tangible assets
0.090.110.060.03-0.11
Graham Net
0.270.70.960.910.44
Working capital
822.09M825.36M1.31B1.14B829.62M
Tangible asset value
1.33B1.26B1.38B1.33B1.02B
Net current asset value
636.49M626.46M802.48M732.75M411.72M
Invested capital
0.290.190.730.650.55
Average receivables
206.6M223.83M226.23M178.72M127.95M
Average payables
138M138M94.9M58.8M64.28M
Average inventory
80.42M79.55M79.44M60.37M50.4M
Days sales outstanding
43.955.1174.9774.85131.32
Days payables outstanding
256.04219.67130.13148.46260.5
Days of inventory on hand
125.23146.89161.95123.51192.62
Receivables turnover
8.316.624.874.882.78
Payables turnover
1.431.662.82.461.4
Inventory turnover
2.912.482.252.961.89
ROE
0.130.150.110.05-0.17
Capex per share
-0.24-0.02-0.09-0.08-0.05

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.070.050.10.050.05
Net income per share
-0.15-0.16-0.03-0.06-0.03
Operating cash flow per share
-0.15-0.16-0.03-0.010.01
Free cash flow per share
-0.17-0.19-0.05-0.010
Cash per share
1.371.231.291.181.08
Book value per share
1.881.451.451.391.24
Tangible book value per share
1.71.31.31.241.11
Share holders equity per share
1.881.451.451.391.24
Interest debt per share
0.750.790.890.850.79
Market cap
3.76B4.49B4.23B3.56B4.31B
Enterprise value
3.74B4.54B4.4B3.78B4.49B
P/E ratio
-8.91-8.9-46-19.07-40.07
Price to sales ratio
73.74118.157.7189.95114.07
POCF ratio
-35.65-35.59-184-462.36609.87
PFCF ratio
-32.53-29.49-113.29-374.971.89K
P/B Ratio
2.913.963.83.364.16
PTB ratio
2.913.963.83.364.16
EV to sales
73.45119.2660.0895.47118.84
Enterprise value over EBITDA
-34.28-43.14-264.15-83.51-381.74
EV to operating cash flow
-35.5-35.94-191.54-490.71635.4
EV to free cash flow
-32.4-29.78-117.94-397.961.97K
Earnings yield
-0.03-0.03-0.01-0.01-0.01
Free cash flow yield
-0.03-0.03-0.0100
Debt to equity
0.40.550.610.610.63
Debt to assets
0.270.330.360.360.36
Net debt to EBITDA
0.14-0.42-10.4-4.82-15.34
Current ratio
6.373.743.193.473.24
Interest coverage
-97.09668.09-18.15-54.41-28.27
Income quality
1110.16-0.26
Dividend Yield
0.020000
Payout ratio
-0.69-0.02-0.05-0.02-0.03
Sales general and administrative to revenue
1.01-1.160.25-0.181.37
Research and developement to revenue
0.140.360.050.250.21
Intangibles to total assets
0.070.060.060.060.06
Capex to operating cash flow
0.10.210.620.23-0.68
Capex to revenue
-0.2-0.69-0.2-0.05-0.13
Capex to depreciation
-0.6-1.56-1.16-0.150.23
Stock based compensation to revenue
00000
Graham number
2.552.290.991.380.95
ROIC
-0.06-0.07-0.01-0.03-0.02
Return on tangible assets
-0.06-0.07-0.01-0.03-0.02
Graham Net
0.70.440.410.340.27
Working capital
960.58M829.62M812.56M751.6M736.96M
Tangible asset value
1.16B1.02B998.15M949.39M924.22M
Net current asset value
546.13M411.72M387.25M319.28M297.21M
Invested capital
0.40.550.610.610.63
Average receivables
166.38M126.86M109.98M99.66M80.2M
Average payables
49.66M58.25M69.37M69.21M75.69M
Average inventory
44.62M47.26M57.11M57.07M58.78M
Days sales outstanding
264.45246.13142.3189.53183.56
Days payables outstanding
181.89173.59236.15199.28351.42
Days of inventory on hand
164.97128.36212.63147.78282.44
Receivables turnover
0.340.370.630.470.49
Payables turnover
0.490.520.380.450.26
Inventory turnover
0.550.70.420.610.32
ROE
-0.08-0.11-0.02-0.04-0.03
Capex per share
-0.01-0.03-0.020-0.01

603669.SS Frequently Asked Questions

What is Lionco Pharmaceutical Group Co.,Ltd. stock symbol ?

Lionco Pharmaceutical Group Co.,Ltd. is a CN stock and trading under the symbol 603669.SS

What is Lionco Pharmaceutical Group Co.,Ltd. stock quote today ?

Lionco Pharmaceutical Group Co.,Ltd. stock price is $4 today.

Is Lionco Pharmaceutical Group Co.,Ltd. stock public?

Yes, Lionco Pharmaceutical Group Co.,Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap